Systematic review / meta-analysis / 2013
Saffron supplementation reduced depressive symptoms compared to placebo in adults with depression.
A meta-analysis of five randomized controlled trials assessed saffron supplementation for major depressive disorder. Saffron significantly reduced depressive symptoms compared with placebo (mean effect size = 1.62, P < 0.001 across 2 trials). Compared with standard antidepressants across 3 trials, saffron showed a null effect size (mean effect size = -0.15), indicating similar efficacy in mitigating depressive symptoms.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 5 randomized controlled trials in adults with major depressive disorder
- What was measured
- Depressive symptoms
THE PAPER
Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.
Hausenblas HA, Saha D, Dubyak PJ, Anton SD. J Integr Med, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.